Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 1/20 | 0.49 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 8/20 | 0.42 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1360401 | 0.85 | PRMT1 (0.63) | ADRA1APRMT1RECQLPLA2G2ATSHR | |
| SCHEMBL5533492 | 0.85 | PRMT1 (0.63) | ADRA1APRMT1RECQLPLA2G2ATSHR | |
| SCHEMBL5536342 | 0.85 | PRMT1 (0.63) | ADRA1APRMT1RECQLPLA2G2ATSHR | |
| SCHEMBL5531367 | 0.85 | PRMT1 (0.63) | ADRA1APRMT1RECQLPLA2G2ATSHR | |
| SCHEMBL5533323 | 0.85 | PRMT1 (0.63) | ADRA1APRMT1RECQLPLA2G2ATSHR | |
| SCHEMBL5535128 | 0.85 | PRMT1 (0.63) | ADRA1APRMT1RECQLPLA2G2ATSHR | |
| SCHEMBL5536799 | 0.85 | PRMT1 (0.63) | ADRA1APRMT1RECQLPLA2G2ATSHR | |
| SCHEMBL5538332 | 0.85 | PRMT1 (0.63) | ADRA1APRMT1RECQLPLA2G2ATSHR | |
| SCHEMBL5535532 | 0.85 | PRMT1 (0.63) | ADRA1APRMT1RECQLPLA2G2ATSHR | |
| SCHEMBL1298943 | 0.85 | PRMT1 (0.63) | ADRA1APRMT1RECQLPLA2G2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090139537-A1 | HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE | L'OREAL S.A. | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090139537-A1 | HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE | KRT18, INMT, INHA | ADRA1A 2192/4885PRMT1 65/4885RECQL 321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.